Potential prodrugs of inhibitors of VEGF-induced angiogenesis have been investigated. The prodrug systems studied were the 4-nitrobenzyl, 2-nitrophenylacetyl and 3-methyl-3-(3,6-dimethylbenzo-1,4-quinon-2-yl)butanoyl groups, readily attached to acidic OH or NH groups in drug molecules, and released upon bioreductive activation. The anti-angiogenic compounds studied were the pyrrolylmethylidenyl oxindole SU5416 (semaxanib) and its novel 6-hydroxy derivative. The potentially pro-anti-angiogenic compounds were assayed for their ability to block VEGF-induced angiogenesis in HUVECS in comparison to the free agents.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2006.12.108DOI Listing

Publication Analysis

Top Keywords

vegf-induced angiogenesis
8
synthesis evaluation
4
evaluation prodrugs
4
prodrugs anti-angiogenic
4
anti-angiogenic pyrrolylmethylidenyl
4
pyrrolylmethylidenyl oxindoles
4
oxindoles potential
4
potential prodrugs
4
prodrugs inhibitors
4
inhibitors vegf-induced
4

Similar Publications

DCBLD1 Modulates Angiogenesis by Regulation of the VEGFR-2 Endocytosis in Endothelial Cells.

Arterioscler Thromb Vasc Biol

December 2024

Department of Biochemistry and Molecular Biology, School of Basic Medicine, Hebei Medical University, Shijiazhuang, China. (Q.F., L.G., C.Y., X.L., Y.L., C.L., W.Z., Y.Z., W.Y., Y.M., R.W., L.L., Y.P., H.W., M.H., L.N.).

Background: Unwanted angiogenesis is involved in the progression of various malignant tumors and cardiovascular diseases, and the factors that regulate angiogenesis are potential therapeutic targets. We tested the hypothesis that DCBLD1 (discoidin, CUB, and LCCL domain-containing protein 1) is a coreceptor of VEGFR-2 (vascular endothelial growth factor receptor-2) and modulates angiogenesis in endothelial cells.

Methods: A carotid artery ligation model and retinal angiogenesis assay were used to study angiogenesis using globe knockout or endothelial cell-specific conditional knockout mice in vivo.

View Article and Find Full Text PDF

Translationally controlled tumor protein (TCTP) is a regulatory protein that plays pivotal roles in cellular processes including the cell cycle, apoptosis, microtubule stabilization, embryo development, stress responses, and cancer. However, the molecular mechanism by which it promotes tumor angiogenesis is still unclear. In this study, we explored the mechanisms underlying stimulation of angiogenesis by a novel TCTP.

View Article and Find Full Text PDF

Endomucin regulates the endothelial cytoskeleton independently of VEGF.

Exp Eye Res

January 2025

Schepens Eye Research Institute of Massachusetts Eye and Ear, Boston, MA, USA; Department of Ophthalmology, Harvard Medical School, Boston, MA, USA; Department of Pathology, Harvard Medical School, Boston, MA, USA. Electronic address:

The endothelial glycocalyx, lining the apical surface of the endothelium, is involved in a host of vascular processes. The glycocalyx is comprised of a network of membrane-bound proteoglycans and glycoproteins along with associated plasma proteins. One such glycoprotein is endomucin (EMCN), which our lab has revealed is a modulator of VEGFR2 function.

View Article and Find Full Text PDF

Apolipoprotein A-I Mimetic Peptide Restores VEGF-induced Angiogenesis in Hypercholesterolemic Ischemic Heart by Reducing HDL Proinflammatory Properties.

J Cardiovasc Transl Res

October 2024

Division of Cardiac Surgery, Cardiovascular Diseases Institute, The First Affiliated Hospital, Sun Yat-Sen University, 58 Zhong Shan Er Road, Guangzhou, 510080, China.

Article Synopsis
  • VEGF-induced angiogenesis is hindered in hypercholesterolemia, but a peptide called D-4F may help improve this condition by reducing HDL's pro-inflammatory effects.
  • In a study, different mouse models were used to assess the impact of D-4F and VEGFA on heart function and angiogenesis after inducing a heart attack.
  • The results indicated that D-4F, when combined with VEGFA, enhanced angiogenesis and improved heart function in hypercholesterolemic mice by activating specific signaling pathways, although it did not have the same effect in another set of genetically modified mice.
View Article and Find Full Text PDF

Age-related macular degeneration (AMD), often triggered by endothelial barrier disruption through vascular endothelial growth factor (VEGF), is a leading cause of blindness. This study investigated the inhibitory effects of phenolic compounds on VEGF-induced endothelial cell proliferation, migration, angiogenesis, and permeability using human retinal microvascular endothelial cells (hRECs). Thirty-seven polyphenolic compounds were selected from various databases based on their antioxidant properties, abundance in food, and solubility.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!